OUR TEAM
Over 140+ Years of Combined Professional Expertise in the Medical Industry. Our interdisciplinary team brings together clinical excellence, deep research expertise, regulated software development, automation experience, and MedTech commercialization to shape the future of volumetric histology.
01
Diagnostic
Excellence
02
IVD
Development
03
Assay, Hardware &
MedTech Expertise
OUR FOUR CO-FOUNDERS

DR. FABIAN MOHR
Managing Director
Head of Business Development
Combines cancer research, software development, strategic consulting, venture capital, and life-science company building experience. Transforms LIMAA's scientific innovation into strategy, partnerships, financing logic, market positioning, and long-term business development.

MÉLANIE GUENTER
Managing Director
Head of Operations & IT
Brings more than two decades of experience at the interface of regulatory and quality management, finance, software development, operations and process excellence. Builds the structures, processes and leadership discipline needed to turn complexity into scalable execution and operational reliability.

CAMILA TOMIKAWA, MD
Head of MA & SA
Head of Pathology
Pathologist with medical informatics expertise and experience advising digital pathology startups on AI model development, validation, and clinical decision-support systems. Connects LIMAA's technology to real laboratory workflows, clinical validation requirements, and pathologist-centered usability.

DR. DR. RENÉ HÄGERLING
ppa.
Head of Research
Chemist and board‑certified human geneticist with deep expertise in 3D histology, light‑sheet microscopy, nanobody‑based staining and translational tissue analysis. Provides the scientific and technological core of LIMAA: non-destructive 3D histopathology, spatial tissue analysis, and clinical translation.
MANAGEMENT
OUR MISSION



